Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by ...

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through ...

Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery

Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective ...

Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors

Recludix is also advancing a potential first-in-class BTK SH2 domain inhibitor for B cell or mast cell-driven I&I diseases, as well as additional discovery programs. Recludix was named a 2024 Fierce ...

Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

By Sneha S K Jan 9 (Reuters) - Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical ...
PharmiWeb

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Morningstar

Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine ...
Nasdaq

Eli Lilly Launches $1 Bln AI Drug Discovery Platform TuneLab

(RTTNews) - Eli Lilly and Co. (LLY), a pharmaceutical company, on Tuesday announced the launch of Lilly TuneLab, an artificial intelligence and machine learning platform designed to give biotech ...